Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer

Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer

Background Microorganisms that can be used for their lytic activity against tumor cells as well as inducing or reactivating antitumor immune responses are a relevant part of the available immunotherapy strategies. Viruses, bacteria and even protozoa have been largely explored with success as effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Louis Lantier, Agathe Poupee-Beauge, Céline Ducournau, Stéphanie Germon, Nathalie Moiré, Antoine Touze, Isabelle Dimier-Poisson, Anne di Tommaso, Mathieu Epardaud, Zineb Lakhrif, Françoise Debierre-Grockiego, Marie-Noëlle Mévélec, Arthur Battistoni, Loïs Coënon, Nora Deluce-Kakwata-Nkor, Florence Velge-Roussel, Céline Beauvillain, Thomas Baranek, Gordon Scott Lee, Thibault Kervarrec
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001242.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/8/2/e001242.full

Similar Items